Glucomannan related health claims

Tabs

Article
konjac mannan, glucomannan, glycaemic control, weight management, body weight, blood lipids, blood glucose, bowel function, intestinal transit, potentially pathogenic organisms, health claims
First published in the EFSA Journal
19. Oktober 2010
Adopted
10. September 2010
Last Updated
9. Dezember 2010. This version replaces the previous one/s.
Type
Scientific Opinion
Abstract

No abstract available

Panel members at the time of adoption
Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen.
Panel on Dietetic Products, Nutrition and Allergies
Contact
nda [at] efsa.europa.eu
doi
10.2903/j.efsa.2010.1798
EFSA Journal 2010;8(10):1798 [27 pp.].
On request from
European Commission
Print on demand
Number of Pages
27